These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21739916)

  • 1. IPAB likely to put pressure on Medicare Advantage & Part D.
    Carroll J
    Manag Care; 2011 Jun; 20(6):5-6. PubMed ID: 21739916
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare program; medical loss ratio requirements for the Medicare Advantage and the Medicare Prescription Drug Benefit Programs.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2013 May; 78(100):31283-313. PubMed ID: 23705177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Independent Payment Advisory Board.
    Manchikanti L; Falco FJ; Singh V; Benyamin RM; Hirsch JA
    Pain Physician; 2011; 14(4):E313-42. PubMed ID: 21785484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for contract year 2012 and other changes. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Apr; 76(73):21431-577. PubMed ID: 21513175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The $150 billion swindle. The case against Medicare Advantage is overwhelming; when will D.C. get wise?
    Sloane T
    Mod Healthc; 2007 Sep; 37(37):17. PubMed ID: 17958047
    [No Abstract]   [Full Text] [Related]  

  • 6. Funding up for grabs in Medicare advantage.
    Diamond F
    Manag Care; 2010 Oct; 19(10):34-7. PubMed ID: 21049787
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare Advantage reconsidered. Congressional subcommittees look into problems.
    DoBias M
    Mod Healthc; 2007 Oct; 37(41):8-9. PubMed ID: 17974063
    [No Abstract]   [Full Text] [Related]  

  • 8. The Independent Payment Advisory Board--Congress's "good deed".
    Aaron HJ
    N Engl J Med; 2011 Jun; 364(25):2377-9. PubMed ID: 21561342
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
    Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPAB not so scary? If spending trend continues, payment board may not meet in this decade.
    Zigmond J
    Mod Healthc; 2013 Jan; 43(2):16. PubMed ID: 23390699
    [No Abstract]   [Full Text] [Related]  

  • 11. Oversight under fire. Audit criticizes Medicare Advantage watchdog.
    Carlson J
    Mod Healthc; 2013 Jan; 43(2):10. PubMed ID: 23390696
    [No Abstract]   [Full Text] [Related]  

  • 12. Losing some advantage. Reform law's changes to affect Medicare Advantage plans--plus and minus.
    Zigmond J
    Mod Healthc; 2011 Jun; 41(23):32-3. PubMed ID: 21710950
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2012 Jan; 77(8):1877-83. PubMed ID: 22359793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IPAB punching bag. New Mass. cost-control panel could provide ammunition for its defenders.
    Goozner M
    Mod Healthc; 2013 Aug; 43(34):20. PubMed ID: 24044299
    [No Abstract]   [Full Text] [Related]  

  • 16. Bending the health cost curve: the promise and peril of the Independent Payment Advisory Board.
    Marciarille AM; DeLong JB
    Health Matrix Clevel; 2012; 22(1):75-121. PubMed ID: 22616543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare advantage to remain robust this year.
    Manag Care; 2013 Jan; 22(1):51. PubMed ID: 23373144
    [No Abstract]   [Full Text] [Related]  

  • 18. Will the IPAB "bend the curve?".
    Ruffner BW
    Tenn Med; 2011 Feb; 104(2):5. PubMed ID: 21387887
    [No Abstract]   [Full Text] [Related]  

  • 19. 'Crushing blow'. Insurers will likely see Medicare Advantage cuts.
    Zigmond J
    Mod Healthc; 2013 Feb; 43(8):8-9. PubMed ID: 23516782
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drugs and administrative costs.
    Grogan CM
    J Health Polit Policy Law; 2013 Jun; 38(3):475-7. PubMed ID: 23674547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.